MedTrace Logo

Effect of Treating Sleep Disorder Breathing in Patients With Resistant Hypertension

NCT00973531 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2012-01-26

No results posted yet for this study

Summary

The investigators would like to investigate the effects of treating sleep apnea with a positive airway pressure device, either continuous (titrated) versus auto titrated on the control of blood pressure in patients with Resistant Hypertension.

Conditions

Interventions

DEVICE

Autotitrating Positive Airway Pressure (APAP)

Then subjects will use Autotitrating Positive Airway Pressure machine for 90 days

DEVICE

Traditional Split Titration Polysomnogram

Then subjects will use Continuous Positive Airway Pressure (CPAP) machine for 90 days

Sponsors & Collaborators

  • Albert Einstein Healthcare Network

    lead OTHER

Principal Investigators

  • Darshak Karia, MD · Albert Einstein Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00973531 on ClinicalTrials.gov